AI excels at identifying patterns and generating insights across large datasets, but its output quality depends heavily on its training data. Meanwhile, projects involve making critical decisions – decisions that require a nuanced understanding of biology, subject-matter expertise and experience that AI lacks. That’s where humans come in.

Our fireside chat will explore a hybrid workflow that combines the best of both worlds: AI efficiency and human intelligence. Led by experts from Sygnature Discovery, we will discuss how this modern approach benefits drug discovery, shortening the path from target lists to confident decisions.